Insights

Credible Foundations Leverage BioSolveIT’s published, transparent science behind SeeSAR and infiniSee to position the company as a trustworthy choice for pharma and biotech decision-makers. Propose pilot projects and reference cases to drive adoption among chemists and R&D leaders seeking validated drug discovery software.

Cross-Platform Upsell Opportunity to upsell through bundled licenses for SeeSAR and infiniSee, offering integrated workflows that connect structure-based and ligand-based discovery. Highlight data interoperability with datasets like eMolecules and provide onboarding and training to accelerate time-to-value.

Scale and Automate Release momentum with infiniSee Arke signaling scalable exploration of vast chemical spaces. Target organizations with large compound libraries by offering scalable visualization, automation-friendly pipelines, and flexible deployment options (cloud or on-prem) plus enterprise security features.

Strategic Partnerships Active community engagement through Drugathon and symposia creates opportunities for co-marketing, sponsorships, and joint webinars. Use these events to generate qualified leads, build credibility, and establish partnerships with pharma, biotech, and academic institutions in Europe.

EU Market Focus German base and mid-sized team align with European pharma and biotech buyers. Localized sales, regulatory alignment, and flexible pricing/licensing can accelerate adoption; consider channel partnerships to expand reach in Europe and other regulated markets.

BioSolveIT Tech Stack

BioSolveIT uses 8 technology products and services including jsDelivr, Argo CD, Slick, and more. Explore BioSolveIT's tech stack below.

  • jsDelivr
    Content Delivery Network
  • Argo CD
    Devops
  • Slick
    Javascript Libraries
  • jQuery UI
    Javascript Libraries
  • .NET
    Programming Languages
  • Yoast SEO
    Search Engines
  • Piwik
    System Analytics & Monitoring
  • Sitelinks Search Box
    Web Tools And Plugins

Media & News

BioSolveIT's Email Address Formats

BioSolveIT uses at least 2 format(s):
BioSolveIT Email FormatsExamplePercentage
First.Last@biosolveit.comJohn.Doe@biosolveit.com
100%
First.Last@biosolveit.deJohn.Doe@biosolveit.de
75%
Last@biosolveit.deDoe@biosolveit.de
25%

Frequently Asked Questions

What is BioSolveIT's official website and social media links?

Minus sign iconPlus sign icon
BioSolveIT's official website is biosolveit.de and has social profiles on LinkedIn.

What is BioSolveIT's NAICS code?

Minus sign iconPlus sign icon
BioSolveIT's NAICS code is 5112 - Software Publishers.

How many employees does BioSolveIT have currently?

Minus sign iconPlus sign icon
As of July 2026, BioSolveIT has approximately 33 employees across 2 continents, including EuropeNorth America. Key team members include Head Of Product: A. A. P. G.Co-Founder And Stakeholder: M. R.Svp Application Science: M. G.. Explore BioSolveIT's employee directory with LeadIQ.

What industry does BioSolveIT belong to?

Minus sign iconPlus sign icon
BioSolveIT operates in the Software Development industry.

What technology does BioSolveIT use?

Minus sign iconPlus sign icon
BioSolveIT's tech stack includes jsDelivrArgo CDSlickjQuery UI.NETYoast SEOPiwikSitelinks Search Box.

What is BioSolveIT's email format?

Minus sign iconPlus sign icon
BioSolveIT's email format typically follows the pattern of First.Last@biosolveit.com. Find more BioSolveIT email formats with LeadIQ.

When was BioSolveIT founded?

Minus sign iconPlus sign icon
BioSolveIT was founded in 2001.
BioSolveIT logo

BioSolveIT

Software DevelopmentNorth Rhine-Westphalia, Germany11-50 Employees

BioSolveIT develops software to support drug discovery, focusing on visualization that helps chemists interpret computational results, and it is based in Sankt Augustin, North Rhine-Westphalia. The tools are described as fast and easy to use, enabling researchers to advance their work and gain clear insights. The company emphasizes transparency by publishing the science behind its software and positions SeeSAR and infiniSee to support structure-based and ligand-based drug discovery. Its customers are chemists and other drug-discovery researchers who need to navigate large chemical spaces and interpret complex computational outputs. In May 2026, BioSolveIT released infiniSee 7.1 'Arke' to enhance exploration of chemical spaces.

Section iconCompany Overview

NAICS Code
5112 - Software Publishers
Founded
2001
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    BioSolveIT's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    BioSolveIT's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.